Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trials
Abstract Purpose Buyang Huanwu decoction (BHD) is a widely used traditional Chinese medicine for the rehabilitation of ischemic stroke patients in China, but its clinical efficacy and safety have not been adequately assessed. In this paper, we conducted a systematic review and meta-analysis to evalu...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-03-01
|
| Series: | Health and Quality of Life Outcomes |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12955-021-01728-6 |
| _version_ | 1818915469416988672 |
|---|---|
| author | Li Gao Zhuoran Xiao Chunhua Jia Wei Wang |
| author_facet | Li Gao Zhuoran Xiao Chunhua Jia Wei Wang |
| author_sort | Li Gao |
| collection | DOAJ |
| description | Abstract Purpose Buyang Huanwu decoction (BHD) is a widely used traditional Chinese medicine for the rehabilitation of ischemic stroke patients in China, but its clinical efficacy and safety have not been adequately assessed. In this paper, we conducted a systematic review and meta-analysis to evaluate the efficacy and safety of BHD. Methods We searched seven electronic databases from inception to 31 March 2019. The language was limited to Chinese and English. Randomized controlled trials evaluating the efficacy and safety of BHD for the rehabilitation of ischemic stroke patients were included in the meta-analysis. Reviewers independently performed the screening, data extraction, bias assessment, and data analysis. The treatment efficacy was pooled in a meta-analysis using RevMan 5.3 software with a random-effect model. Any disagreement was resolved by discussion among all reviewers. The PRISMA statement was used in the review process. Results A total of 11 studies with 1084 patients were included in the meta-analysis. The results suggested that BHD was superior to other treatments in terms of clinical efficacy in symptoms and daily activities (n = 684, RR = 1.12, 95% CI: 0.99 to 1.27), clinical efficacy in TCM symptoms (n = 280, RR = 1.45, 95% CI: 1.03 to 2.03), National Institute of Health stroke scale (n = 192, MD = 1.66, 95% CI: -1.08 to 4.40), and activities of daily living (n = 200, MD = 8.20, 95% CI: -3.95 to 20.35). Conclusions The results supported the clinical use of BHD for the rehabilitation of ischemic stroke patients. However, the methodological qualities of the included studies were relatively low, and there were limited reports on adverse events. The clinical efficacy and safety of BHD need to be further confirmed by more well-designed and high-quality randomized controlled trials to warrant the clinical recommendation of BHD for the rehabilitation of ischemic stroke patients. |
| first_indexed | 2024-12-20T00:02:46Z |
| format | Article |
| id | doaj.art-32b73c9cbe8444cfa102897779139390 |
| institution | Directory Open Access Journal |
| issn | 1477-7525 |
| language | English |
| last_indexed | 2024-12-20T00:02:46Z |
| publishDate | 2021-03-01 |
| publisher | BMC |
| record_format | Article |
| series | Health and Quality of Life Outcomes |
| spelling | doaj.art-32b73c9cbe8444cfa1028977791393902022-12-21T20:00:46ZengBMCHealth and Quality of Life Outcomes1477-75252021-03-0119111110.1186/s12955-021-01728-6Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trialsLi Gao0Zhuoran Xiao1Chunhua Jia2Wei Wang3School of Traditional Chinese Medicine, Beijing University of Chinese MedicineSchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineSchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineSchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineAbstract Purpose Buyang Huanwu decoction (BHD) is a widely used traditional Chinese medicine for the rehabilitation of ischemic stroke patients in China, but its clinical efficacy and safety have not been adequately assessed. In this paper, we conducted a systematic review and meta-analysis to evaluate the efficacy and safety of BHD. Methods We searched seven electronic databases from inception to 31 March 2019. The language was limited to Chinese and English. Randomized controlled trials evaluating the efficacy and safety of BHD for the rehabilitation of ischemic stroke patients were included in the meta-analysis. Reviewers independently performed the screening, data extraction, bias assessment, and data analysis. The treatment efficacy was pooled in a meta-analysis using RevMan 5.3 software with a random-effect model. Any disagreement was resolved by discussion among all reviewers. The PRISMA statement was used in the review process. Results A total of 11 studies with 1084 patients were included in the meta-analysis. The results suggested that BHD was superior to other treatments in terms of clinical efficacy in symptoms and daily activities (n = 684, RR = 1.12, 95% CI: 0.99 to 1.27), clinical efficacy in TCM symptoms (n = 280, RR = 1.45, 95% CI: 1.03 to 2.03), National Institute of Health stroke scale (n = 192, MD = 1.66, 95% CI: -1.08 to 4.40), and activities of daily living (n = 200, MD = 8.20, 95% CI: -3.95 to 20.35). Conclusions The results supported the clinical use of BHD for the rehabilitation of ischemic stroke patients. However, the methodological qualities of the included studies were relatively low, and there were limited reports on adverse events. The clinical efficacy and safety of BHD need to be further confirmed by more well-designed and high-quality randomized controlled trials to warrant the clinical recommendation of BHD for the rehabilitation of ischemic stroke patients.https://doi.org/10.1186/s12955-021-01728-6Buyang Huanwu decoctionRehabilitationIschemic strokeTraditional Chinese medicineMeta-analysis |
| spellingShingle | Li Gao Zhuoran Xiao Chunhua Jia Wei Wang Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trials Health and Quality of Life Outcomes Buyang Huanwu decoction Rehabilitation Ischemic stroke Traditional Chinese medicine Meta-analysis |
| title | Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trials |
| title_full | Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trials |
| title_fullStr | Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trials |
| title_full_unstemmed | Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trials |
| title_short | Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trials |
| title_sort | effect of buyang huanwu decoction for the rehabilitation of ischemic stroke patients a meta analysis of randomized controlled trials |
| topic | Buyang Huanwu decoction Rehabilitation Ischemic stroke Traditional Chinese medicine Meta-analysis |
| url | https://doi.org/10.1186/s12955-021-01728-6 |
| work_keys_str_mv | AT ligao effectofbuyanghuanwudecoctionfortherehabilitationofischemicstrokepatientsametaanalysisofrandomizedcontrolledtrials AT zhuoranxiao effectofbuyanghuanwudecoctionfortherehabilitationofischemicstrokepatientsametaanalysisofrandomizedcontrolledtrials AT chunhuajia effectofbuyanghuanwudecoctionfortherehabilitationofischemicstrokepatientsametaanalysisofrandomizedcontrolledtrials AT weiwang effectofbuyanghuanwudecoctionfortherehabilitationofischemicstrokepatientsametaanalysisofrandomizedcontrolledtrials |